Track the オンコセラピー・サイエンス株式会社 stock price and the full directors' dealings record of the company, a publicly traded company based in Japan. Shares are quoted on the JP market, under the oversight of EDINET (Japan FSA). Operating in the Health Care sector, オンコセラピー・サイエンス株式会社 has published 58 public disclosures. Market capitalisation: €7.6bn. The latest transaction was disclosed on 15 June 2026 (Holding update). Among the most active insiders: Long Corridor Asset Management Limited. The full history is accessible without an account.
58
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
19Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 28,438 of 29,062 companies
10.2
score / 100
Value
15
Quality
5
FCF yld-11%
Earn yld-10%
EV/EBITDA·
ROE-52%
Gross mgn1.7%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
OncoTherapy Science Inc. es una empresa centrada en el desarrollo de terapias innovadoras para el tratamiento del cáncer. Se especializa en la investigación y comercialización de soluciones terapéuticas en el sector sanitario y farmacéutico.